Method for drug formulation and a pharmaceutical composition
AssigneeKabi Pharmacia AB
InventorsArne Kristensen, Per Holm
Life of this patent
Estimating the term…
Loading patent…
AssigneeKabi Pharmacia AB
InventorsArne Kristensen, Per Holm
Estimating the term…
A melt granulating method for the production of pellets (spheres) which contain a therapeutically active substance of high-dosage type. The method is characterized by: (i) mechanically working a mixture which contains (a) the active substance in cohesive form and (b) a binder (melting point 40.degree. C.-100.degree. C.) while supplying sufficient energy for the binder to melt and to form spherical overwetted pellets; (ii) adding further cohesive substance, while maintaining the mechanical working; (iii) interrupting the mechanical working and supply of energy and cohesive substance when the desired mean particle size of dry pellets (spheres) has been achieved; and (iv) removing the smallest and largest particles and dividing the remaining pellets into dosage batches. A novel pharmaceutical composition containing a dosage of 300-500 mg of pellets is obtainable from this process.
A melt granulating method for producing pellets which contain a therapeutically active substance, comprising, in an intensive mixer,
A pharmaceutical composition containing a dosage of a pelletized cohesive active substance in the form of particles having a mean particle size below 20 .mu.m, comprising pellets containing the active substance and a water-soluble binder having a melting temperature of 40.degree.-100.degree. C., wherein the active substance constitutes 60-95% (w/w) and the binder 5-40% (w/w) of the pellets.
A melt granulating method for producing pellets which contain a therapeutically active substance, comprising, in an intensive mixer,
Dependencies are inferred from the claim text.